1. Home /
    2. Altai Protocol Library /
  2. New Indication: Cemiplimab for locally advanced and metastatic basal cell carcinoma

Altai Protocol Library

1041 protocols and counting

All protocols with references and links

All protocols reviewed by a Medical Oncologist/Hematologist

All protocols in major guidelines included

Ability to create your own protocols

Kütüphanede Ara Ara
Altai Protocol Library

New Indication: Cemiplimab for locally advanced and metastatic basal cell carcinoma

New Indication: Cemiplimab for locally advanced and metastatic basal cell carcinoma
Study:
  • Phase II, open-label (Study 1620)
  • Unresectable locally advanced or metastatic basal cell carcinoma progressed or no response to or intolerant to hedgehog pathway inhibitor therapy (N=112)
  • Cemiplimab 350 q21
Efficacy:
  • Locally advanced: ORR: 29%, 79% of responders maintained for >6 mos
  • Metastatic: ORR: 21%, all responders maintained for >6 mos

Not published yet. See Package insert for Libtayo

Libtayo package insert

Altai Chemo Planner

Quickly Prepare Accurate Chemotherapy Orders

Altai Chemo Planner employs Altai Protocol Library that includes over 1000 chemotherapy protocols for both Hematology and Oncology. You can find major guidelines' protocols, parenteral, and oral, in the library. Altai Protocol Library is frequently and regularly updated.

Learn More